Clinical Trial Update: Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

This clinical trial update summarizes Phase 2 results for ZYIL1 in amyotrophic lateral sclerosis, including efficacy, safety, tolerability, pharmacokinetics, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• ZYIL1

Snippet

Sponsor: Zydus Lifesciences Limited | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED